特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア(POC)グルコース検査の世界市場:製品別 - 規模、シェア、動向、およびセグメント予測(2019年~2025年)

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 917725
出版日 ページ情報 英文 145 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
ポイントオブケア(POC)グルコース検査の世界市場:製品別 - 規模、シェア、動向、およびセグメント予測(2019年~2025年) Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025
出版日: 2019年11月28日 ページ情報: 英文 145 Pages
概要

世界のポイントオブケア(POC)グルコース検査市場は、2018年に60億1,783万米ドルとなりました。同市場は、2025年までの間に2.82%のCAGRで成長する見通しで、2025年には73億869万米ドルに達すると予測されています。

当レポートは世界の世界のポイントオブケア(POC)グルコース検査市場について調査しており、市場規模および動向、製品・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査方法

  • 市場セグメント・範囲
  • 市場の定義
  • 情報調達
  • 情報分析
  • 市場の定式化およびデータの可視化
  • データ検証・公開

第2章 エグゼクティブサマリー

第3章 調査方法

  • 情報調達
  • データ解析

第4章 市場変数、動向、および規模

  • 市場セグメント・範囲
  • 要因別SWOT分析(政治的、法的、経済的、技術的)
  • 産業分析:ポーターのファイブフォース分析
  • パイプライン分析

第5章 市場分析:製品別

  • 市場の動向分析
  • Accu-Chek
  • Onetouch Verio Flex
  • i-STAT
  • FreeStyle Lite
  • Bayer CONTOUR 血糖モニタリングシステム
  • True Metrix
  • Accu-Chek Inform II
    • Accu-Chek Inform IIの使用を支持する要因
  • StatStrip
    • StatStripの使用を支持する要因

第6章 市場分析:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア

第7章 競合情勢

  • 戦略的枠組み
  • 市場参入企業の分類
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 Examples: CLIA waived tests
  • TABLE 2 North America diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 3 Europe diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 4 Asia Pacific diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 5 Latin America diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 6 MEA and Africa diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 7 CIS diabetes prevalence (National prevalence %), 2013 & 2035
  • TABLE 8 Specifications of Accu-Chek
  • TABLE 9 Specifications of Accu-Chek Guide Me meter
  • TABLE 10 Specifications of Accu-Chek Aviva meter
  • TABLE 11 Specifications of Accu-Chek Aviva meter
  • TABLE 12 Specifications of Accu-Chek Nano meter
  • TABLE 13 Specifications of OneTouch Verio Flex meter
  • TABLE 14 Specifications of i-STAT analyser
  • TABLE 15 Specifications of FreeStyle Lite system
  • TABLE 16 Specifications of Bayer CONTOUR meter
  • TABLE 17 Specifications of TRUE METRIX
  • TABLE 18 Features and properties of ACCU-CHEK INFORM II
  • TABLE 19 Specifications of STATSTRIP
  • TABLE 20 STATSTRIP: Improved Sensitivity for Detecting Hypoglycemia
  • TABLE 21 Significant decline in deaths caused by StatStrip
  • TABLE 22 Glucose meter offered by One Drop
  • TABLE 23 HemoCue AB: Glucose POC diagnostics
  • TABLE 24 Dexcom glucose testing products marketed in France
  • TABLE 25 Some of the local glucose POC testing manufacturers in China
  • TABLE 26 Some of the local glucose POC testing manufacturers in India
  • TABLE 27 Primary guidelines for glucose POC testing in Australia
  • TABLE 28 Prevalence of diabetes and related risk factors; 2016
  • TABLE 29 Availability of basic technologies in the Brazilian primary care facilities

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Point-of-care diagnostics: Market trends & outlook
  • FIG. 8 Market segmentation & scope
  • FIG. 9 Glucose point-of-care diagnostics/testing market: Driver relevance analysis (Current & future impact)
  • FIG. 10 Shift in POC molecular diagnostic trends
  • FIG. 11 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (%)
  • FIG. 12 Schematic representation of POCT device connectivity
  • FIG. 13 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
  • FIG. 14 Point-of-care diagnostics: SWOT analysis, by factor (Political & legal, economic, and technological)
  • FIG. 15 Point-of-care diagnostics: Porter's five forces analysis
  • FIG. 16 Glucose point-of-care diagnostics market product outlook key takeaways
  • FIG. 17 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
  • FIG. 18 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
  • FIG. 19 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
  • FIG. 20 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
  • FIG. 21 i-STAT market revenue, 2014 - 2025 (USD Million)
  • FIG. 22 i-STAT market volume, 2014 - 2025 (Thousand Units)
  • FIG. 23 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
  • FIG. 24 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
  • FIG. 25 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
  • FIG. 26 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
  • FIG. 27 True Metrix market revenue, 2014 - 2025 (USD Million)
  • FIG. 28 True Metrix market volume, 2014 - 2025 (Thousand Units)
  • FIG. 29 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
  • FIG. 30 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
  • FIG. 31 StatStrip market revenue, 2014 - 2025 (USD Million)
  • FIG. 32 StatStrip market volume, 2014 - 2025 (Thousand Units)
  • FIG. 33 Regional market place: Key takeaways
  • FIG. 34 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 35 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 36 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 37 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 38 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 39 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 40 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 41 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 42 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 43 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 44 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 45 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 46 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 47 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 48 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 49 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 50 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 51 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 52 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 53 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 54 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 55 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 56 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 57 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 58 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 59 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 60 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 61 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 62 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 63 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 64 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 65 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 66 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 67 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 68 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 69 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 70 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 71 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 72 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 73 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 74 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 75 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 76 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 77 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 78 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
  • FIG. 79 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • FIG. 80 Strategy framework
  • FIG. 81 Participant categorization
目次
Product Code: GVR-4-68038-134-4

The global point-of-care glucose testing market size recorded a revenue of USD 6,017.83 million in 2018 and is expected to reach USD 7,308.69 million by 2025 growing at a CAGR of 2.82%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Further key findings from the study suggest:

  • Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period
  • Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025
  • In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry
  • North America is the leading regional market due to the higher penetration of novel diagnostic techniques
  • Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes
  • A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

Table of Contents

Chapter 1. Research Methodology

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

Chapter 3. Research Methodology

  • 3.1. Information procurement
  • 3.2. Data Analysis

Chapter 4. Point-of-Care Glucose Testing Market Variables, Trends & Scope

  • 4.1. Market Segmentation & Scope
    • 4.1.1. Market driver analysis
      • 4.1.1.1. Introduction of CLIA waived tests
      • 4.1.1.2. Growing prevalence of diabetes
      • 4.1.1.3. Rising demand for short turnaround time glucose POC testing
    • 4.1.2. Market restraint analysis
      • 4.1.2.1. Potential interference and calibration issues in glucose meters
      • 4.1.2.2. Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
  • 4.2. Point-of-care diagnostics SWOT analysis, by factor (Political & legal, economic, and technological)
  • 4.3. Industry Analysis - Porter's
  • 4.4. Pipeline Analysis
    • 4.4.1. Product pipeline by Phase
    • 4.4.2. Pipeline glucose meters; 2017
    • 4.4.3. Product pipeline by Applicant

Chapter 5. Point-of-Care Glucose Testing Market Categorization: Product Estimates & Trend Analysis

  • 5.1 Global Glucose Point-of-Care Diagnostics/Testing Market: Product Movement Analysis
  • 5.2 Accu-Chek
    • 5.2.1 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
    • 5.2.2 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
  • 5.3 Onetouch Verio Flex
    • 5.3.1 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
    • 5.3.2 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
  • 5.4 i-STAT
    • 5.4.1 i-STAT market revenue, 2014 - 2025 (USD Million)
    • 5.4.2 i-STAT market volume, 2014 - 2025 (Thousand Units)
  • 5.5 FreeStyle Lite
    • 5.5.1 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
    • 5.5.2 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
  • 5.6 Bayer CONTOUR Blood Glucose Monitoring System
    • 5.6.1 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
    • 5.6.2 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
  • 5.7 True Metrix
    • 5.7.1 True Metrix market revenue, 2014 - 2025 (USD Million)
    • 5.7.2 True Metrix market volume, 2014 - 2025 (Thousand Units)
  • 5.8 Accu-Chek Inform II
    • 5.8.1 Factors favouring the usage of Accu-Chek Inform II
    • 5.8.2 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
    • 5.8.3 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
  • 5.9 StatStrip
    • 5.9.1 Factors favouring the usage of StatStrip
    • 5.9.2 StatStrip market revenue, 2014 - 2025 (USD Million)
    • 5.9.3 StatStrip market volume, 2014 - 2025 (Thousand Units)

Chapter 6. Point-of-Care Glucose Testing Market Categorization: Regional Estimates & Trend Analysis

  • 6.1 North America
    • 6.1.1 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.1.2 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.1.3 U.S.
      • 6.1.3.1 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.1.3.2 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.1.4 Canada
      • 6.1.4.1 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.1.4.2 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.2 Europe
    • 6.2.1 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.2.2 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.3 Germany
      • 6.2.3.1 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.3.2 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.4 UK
      • 6.2.4.1 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.4.2 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.5 France
      • 6.2.5.1 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.5.2 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.6 Italy
      • 6.2.6.1 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.6.2 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.7 Spain
      • 6.2.7.1 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.7.2 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.2.8 Russia
      • 6.2.8.1 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.2.8.2 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.3.2 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.3 Japan
      • 6.3.3.1 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.3.2 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.4 China
      • 6.3.4.1 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.4.2 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.5 India
      • 6.3.5.1 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.5.2 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.6 Australia
      • 6.3.6.1 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.6.2 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.7 Korea
      • 6.3.7.1 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.7.2 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.3.8 Singapore
      • 6.3.8.1 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.3.8.2 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.4 Latin America
    • 6.4.1 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.4.2 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.4.3 Brazil
      • 6.4.3.1 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.4.3.2 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.4.4 Mexico
      • 6.4.4.1 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.4.4.2 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
  • 6.5 Middle East & Africa.
    • 6.5.1 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
    • 6.5.2 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.5.3 South Africa
      • 6.5.3.1 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.5.3.2 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
    • 6.5.4 Saudi Arabia
      • 6.5.4.1 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
      • 6.5.4.2 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)

Chapter 7. Competitive Landscape

  • 7.1. Strategy Framework
  • 7.2. Market Participation Categorization
  • 7.3. Company Profiles
    • 7.3.1. F. Hoffmann-La Roche Ltd.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Abbott
      • 7.3.2.1. Company overview
      • 7.3.2.2. Alere
      • 7.3.2.2.1. Company overview
      • 7.3.2.3. Financial performance
      • 7.3.2.3.1. Financial performance
      • 7.3.2.4. Product benchmarking
      • 7.3.2.5. Strategic initiatives
    • 7.3.3. Nipro
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
    • 7.3.4. Platinum Equity, LLC. (LifeScan, Inc.)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Product benchmarking/Product portfolio
      • 7.3.4.3. Strategic initiatives
    • 7.3.5. Nova Biomedical
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking/Product portfolio
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. ACON Laboratories, Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking/Product portfolio
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Trividia Health, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking/Product portfolio
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Prodigy Diabetes Care, LLC.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Product benchmarking/Product portfolio
    • 7.3.9. Bayer AG/Ascensia Diabetes Care Holdings AG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Product benchmarking/Product portfolio
      • 7.3.9.3. Financial performance
    • 7.3.10. EKF Diagnostics
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking